Evaluating Co-Expression of EZH2 and MYC in Mantle Cell Lymphoma

被引：0
|
作者：
Patel, Sanjay
Eikhoff, Jens
Shaw, Gene
Kahl, Brad
Yang, David
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1478
引用
收藏
页码：371A / 371A
页数：1
相关论文
共 50 条
  • [21] EZH2: a potential new target in T-cell lymphoma?
    Giulino-Roth, Lisa
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 1924 - 1925
  • [22] Next-generation Sequencing Revealed Frequent TP53 mutation in Mantle Cell Lymphoma with Enhancer of Zeste Homolog 2 (EZH2) Expression
    Kim, Do Hwan
    Li, Shaoying
    Kanagal-Shamanna, Rashmi
    Miranda, Roberto
    Vega-Vazquez, Francisco
    Medeiros, L. Jeffrey
    Ok, Chi Young
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 966 - 967
  • [23] Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma
    Pikman, Yana
    Conway, Amy Saur
    Robichaud, Amanda L.
    Kitara, Samuel
    Church, Alanna J.
    Kennedy, Alyssa L.
    Silverman, Lewis B.
    Billett, Amy L.
    Weinstock, David M.
    Harris, Marian H.
    Stegmaier, Kimberly
    BLOOD ADVANCES, 2020, 4 (07) : 1265 - 1269
  • [24] Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression
    Kuser-Abali, Gamze
    Alptekin, Ahmet
    Cinar, Bekir
    EPIGENETICS, 2014, 9 (04) : 634 - 643
  • [25] The Relationship between EZH2 Expression and Renal Cell Carcinoma
    Lee, H. W.
    Park, J. Y.
    Hwang, I.
    Jung, H. R.
    Kwon, S. Y.
    Kang, Y. N.
    Kim, S. P.
    Kwon, K.
    Lee, S. S.
    Choe, M. S.
    LABORATORY INVESTIGATION, 2012, 92 : 223A - 223A
  • [26] Emerging EZH2 Inhibitors and Their Application in Lymphoma
    Jennifer K. Lue
    Jennifer E. Amengual
    Current Hematologic Malignancy Reports, 2018, 13 : 369 - 382
  • [27] Emerging EZH2 Inhibitors and Their Application in Lymphoma
    Lue, Jennifer K.
    Amengual, Jennifer E.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (05) : 369 - 382
  • [28] Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
    Veija, Tuukka
    Koljonen, Virve
    Bohling, Tom
    Kero, Mia
    Knuutila, Sakari
    Sarhadi, Virinder Kaur
    BMC CANCER, 2017, 17
  • [29] Upregulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-Expression and PRC2 Complex Protein SUZ12 Correlation in Adult T-Cell Leukemia/Lymphoma
    Chai, Jiani
    Choudhuri, Jui
    Gong, Jerald Z.
    Wang, Yanhua
    Tian, Xuejun
    CANCERS, 2024, 16 (03)
  • [30] Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
    Tuukka Veija
    Virve Koljonen
    Tom Bohling
    Mia Kero
    Sakari Knuutila
    Virinder Kaur Sarhadi
    BMC Cancer, 17
12345